The Probiotic Mix VSL#3 is Effective Adjunctive Therapy for Mild-to-Moderately Active Ulcerative Colitis: A Meta-Analysis

Mardini Houssam; Grigorian Alla

首页> 外文期刊>The American Journal of Gastroenterology >The Probiotic Mix VSL#3 is Effective Adjunctive Therapy for Mild-to-Moderately Active Ulcerative Colitis: A Meta-Analysis

【24h】

The Probiotic Mix VSL#3 is Effective Adjunctive Therapy for Mild-to-Moderately Active Ulcerative Colitis: A Meta-Analysis

机译：益生菌混合物VSL＃3是轻度至中度活动性溃疡性结肠炎的有效辅助治疗：一项荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2014年第2期|共1页
作者
Mardini Houssam; Grigorian Alla;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The Probiotic Mix VSL#3 is Effective Adjunctive Therapy for Mild-to-Moderately Active Ulcerative Colitis: A Meta-Analysis [J] . Mardini Houssam, Grigorian Alla The American Journal of Gastroenterology . 2014,第Suppla2期

机译：益生菌混合物VSL＃3是轻度至中度活动性溃疡性结肠炎的有效辅助治疗：一项荟萃分析
2. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. [J] . Sood A, Midha V, Makharia GK, Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2009,第11期

机译：益生菌制剂，VSL＃3诱导患有轻度至中等活性溃疡性结肠炎患者的缓解。
3. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. [J] . Sood A, Midha V, Makharia GK, Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2009,第11期

机译：益生菌制剂，VSL＃3诱导患有轻度至中等活性溃疡性结肠炎患者的缓解。
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Chlor-amidine, a novel PAD inhibitor, as an effective drug for the treatment of ulcerative colitis and prevention of colorectal cancer. [D] . Witalison, Erin. 2016

机译：氯-，一种新型的PAD抑制剂，是治疗溃疡性结肠炎和预防结直肠癌的有效药物。
6. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis [O] . Xiaofei Dang, Mingjie Xu, Duanrui Liu, 2020

机译：评估粪便微生物群移植和益生菌VSL＃3对活性溃疡性结肠炎的疗效和安全性：系统评价和荟萃分析
7. Treatment of relapsing mild-to-moderate ulcerative colitis with the\ud probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a\ud double-blind, randomized, placebo-controlled study [O] . TURSI A, BRANDIMARTE G, PAPA A, 2010

机译：\ ud治疗复发性轻度至中度溃疡性结肠炎益生菌VSL＃3作为标准药物治疗的辅助剂：a \ ud 双盲，随机，安慰剂对照研究

The Probiotic Mix VSL#3 is Effective Adjunctive Therapy for Mild-to-Moderately Active Ulcerative Colitis: A Meta-Analysis

著录项

相似文献

相关主题

期刊订阅